Cited by 119Alzheimer's disease research and treatmentsViral-associated cancers and disordersCytomegalovirus and herpesvirus research

Human Herpesvirus 6 Detection in Alzheimer’s Disease Cases and Controls across Multiple Cohorts

Open access
Allnutt, Mary Alice, Johnson, Kory, Bennett, David A., Connor, Sarah M., Troncoso, Juan C., Pletnikova, Olga, Albert, Marilyn S., Resnick, Susan M. +3 more·2020·Neuron

Abstract

The interplay between viral infection and Alzheimer's disease (AD) has long been an area of interest, but proving causality has been elusive. Several recent studies have renewed the debate concerning the role of herpesviruses, and human herpesvirus 6 (HHV-6) in particular, in AD. We screened for HHV-6 detection across three independent AD brain repositories using (1) RNA sequencing (RNA-seq) datasets and (2) DNA samples extracted from AD and non-AD control brains. The RNA-seq data were screened for pathogens against taxon references from over 25,000 microbes, including 118 human viruses, whereas DNA samples were probed for PCR reactivity to HHV-6A and HHV-6B. HHV-6 demonstrated little specificity to AD brains over controls by either method, whereas other viruses, such as Epstein-Barr virus (EBV) and cytomegalovirus (CMV), were detected at comparable levels. These direct methods of viral detection do not suggest an association between HHV-6 and AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2019.12.031

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent analyses of post-mortem samples indicate HHV6 may be more abundant in the brains of AD individuals, but these results were contrasted by a re-analysis of the same samples using different bioinformatic techniques.

    “Although recent analyses of post-mortem samples indicate HHV6 may be more abundant in the brains of AD individuals, these results were contrasted by a re-analysis of the same samples using different bioinformatic techniques [43,44].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 58 · Cited by 119

Research works printed but not linked: 48

  1. Agostini S, Mancuso R, Baglio F, Cabinio M, Hernis A, Guerini FR, Calabrese E, Nemni R, and Clerici M (2016). Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer’s disease. J Alzheimers Dis 49, 229– 235. 26444787
  2. Balin BJ, and Hudson AP (2014). Etiology and pathogenesis of late-onset Alzheimer’s disease. Curr Allergy Asthma Rep 14, 417. 24429902
  3. Ball MJ (1982). “ Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?”. Can J Neurol Sci 9, 303– 306. 7116237
  4. Bartolini L, Piras E, Sullivan K, Gillen S, Bumbut A, Lin CM, Leibovitch EC, Graves JS, Waubant EL, Chamberlain JM, (2018). Detection of HHV-6 and EBV and Cytokine Levels in Saliva From Children With Seizures: Results of a Multi-Center Cross-Sectional Study. Front Neurol 9, 834. 30344507 PMC6182262
  5. Bartsch T, Rempe T, Leypoldt F, Riedel C, Jansen O, Berg D, and Deuschl G (2019). The spectrum of progressive multifocal leukoencephalopathy: a practical approach. Eur J Neurol 26, 566– e541. 30629326
  6. Bennett DA, Schneider JA, Arvanitakis Z, and Wilson RS (2012a). Overview and findings from the religious orders study. Curr Alzheimer Res 9, 628– 645. 22471860 PMC3409291
  7. Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, and Wilson RS (2012b). Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res 9, 646– 663. 22471867 PMC3439198
  8. Blauwendraat C, Pletnikova O, Geiger JT, Murphy NA, Abramzon Y, Rudow G, Mamais A, Sabir MS, Crain B, Ahmed S, (2019). Genetic analysis of neurodegenerative diseases in a pathology cohort. Neurobiol Aging 76, 214 e211– 214 e219. PMC6391207 30528841
  9. Bookstaver PB, Mohorn PL, Shah A, Tesh LD, Quidley AM, Kothari R, Bland CM, and Weissman S (2017). Management of Viral Central Nervous System Infections: A Primer for Clinicians. J Cent Nerv Syst Dis 9, 1179573517703342. 28579869 PMC5415352
  10. Brody DL, Jiang H, Wildburger N, and Esparza TJ (2017). Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease. Alzheimers Res Ther 9, 62. 28818091 PMC5561579
  11. Carbone I, Lazzarotto T, Ianni M, Porcellini E, Forti P, Masliah E, Gabrielli L, and Licastro F (2014). Herpes virus in Alzheimer’s disease: relation to progression of the disease. Neurobiol Aging 35, 122– 129. 23916950
  12. Cermelli C, Berti R, Soldan SS, Mayne M, D’Ambrosia J M, Ludwin SK, and Jacobson S (2003). High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 187, 1377– 1387. 12717618
  13. Chan PK, Ng HK, Hui M, and Cheng AF (2001). Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain. J Med Virol 64, 42– 46. 11285567
  14. Chapenko S, Roga S, Skuja S, Rasa S, Cistjakovs M, Svirskis S, Zaserska Z, Groma V, and Murovska M (2016). Detection frequency of human herpesviruses-6A, -6B, and -7 genomic sequences in central nervous system DNA samples from post-mortem individuals with unspecified encephalopathy. J Neurovirol 22, 488– 497. 26727906
  15. Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ, Gyorgy B, Breakefield XO, Tanzi RE, and Moir RD (2018). Alzheimer’s Disease-Associated beta-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection. Neuron 99, 56– 63.e53. 30001512 PMC6075814
  16. Fessel J (2018). Amyloid is essential but insufficient for Alzheimer causation: addition of subcellular cofactors is required for dementia. Int J Geriatr Psychiatry 33, e14– e21. 28509380
  17. Flamand L (2018). Chromosomal Integration by Human Herpesviruses 6A and 6B. Adv Exp Med Biol 1045, 209– 226. 29896669
  18. Goldschmidt-Clermont PJ, Volinsky FG, LaRosa SP, Gilbert JR, and Pericak-Vance MA (2019). Time for Well-Powered Controlled Prospective Studies to test a Causal Role for Herpes Viruses in Alzheimer Using Anti-Herpes Drugs. J Gerontol A Biol Sci Med Sci. PMC13376657 31175818
  19. Haas JG, and Lathe R (2018). Microbes and Alzheimer’s Disease: New Findings Call for a Paradigm Change. Trends Neurosci 41, 570– 573. 30033181
  20. Hemling N, Roytta M, Rinne J, Pollanen P, Broberg E, Tapio V, Vahlberg T, and Hukkanen V (2003). Herpesviruses in brains in Alzheimer’s and Parkinson’s diseases. Ann Neurol 54, 267– 271. 12891684
  21. Holmes C (2013). Review: systemic inflammation and Alzheimer’s disease. Neuropathol Appl Neurobiol 39, 51– 68. 23046210
  22. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, and Jamieson GA (1997). Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet 349, 241– 244. 9014911
  23. Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, Lefkowitz A, McColl G, Goldstein LE, Tanzi RE, and Moir RD (2016). Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med 8, 340ra372. PMC5505565 27225182
  24. Leibovitch EC, Brunetto GS, Caruso B, Fenton K, Ohayon J, Reich DS, and Jacobson S (2014). Coinfection of human herpesviruses 6A (HHV-6A) and HHV-6B as demonstrated by novel digital droplet PCR assay. PLoS One 9, e92328. 24663487 PMC3963908
  25. Leibovitch EC, and Jacobson S (2018). Viruses in chronic progressive neurologic disease. Mult Scler 24, 48– 52. 29307291 PMC5777331
  26. Leibovitch EC, Lin CM, Billioux BJ, Graves J, Waubant E, and Jacobson S (2019). Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls. Mult Scler 25, 644– 652. 29569515 PMC6119543
  27. Lin CT, Leibovitch EC, Almira-Suarez MI, and Jacobson S (2016). Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls. Infect Agent Cancer 11, 32. 27462365 PMC4960850
  28. Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, and Itzhaki RF (2002). Herpesviruses in brain and Alzheimer’s disease. J Pathol 197, 395– 402. 12115887
  29. Liu C, Chyr J, Zhao W, Xu Y, Ji Z, Tan H, Soto C, Zhou X, and, f.t.A.s.D.N.I. (2018). Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer’s Disease Development. Frontiers in Genetics 9. PMC6166008 30319691
  30. Miklossy J (2015). Historic evidence to support a causal relationship between spirochetal infections and Alzheimer’s disease. Front Aging Neurosci 7, 46. 25932012 PMC4399390
  31. Moir RD, and Tanzi RE (2019). Low Evolutionary Selection Pressure in Senescence Does Not Explain the Persistence of Abeta in the Vertebrate Genome. Front Aging Neurosci 11, 70. 30983989 PMC6447958
  32. Nath A (2015). Neurologic Complications of Human Immunodeficiency Virus Infection. Continuum (Minneap Minn) 21, 1557– 1576. 26633776
  33. Qin Q, and Li Y (2019). Herpesviral infections and antimicrobial protection for Alzheimer’s disease: Implications for prevention and treatment. J Med Virol. 30997676
  34. Readhead B, Haure-Mirande JV, Funk CC, Richards MA, Shannon P, Haroutunian V, Sano M, Liang WS, Beckmann ND, Price ND, (2018). Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron 99, 64– 82 e67. 29937276 PMC6551233
  35. Regen F, Hellmann-Regen J, Costantini E, and Reale M (2017). Neuroinflammation and Alzheimer’s Disease: Implications for Microglial Activation. Curr Alzheimer Res 14, 1140– 1148. 28164764
  36. Rizzo R, Bortolotti D, Gentili V, Rotola A, Bolzani S, Caselli E, Tola MR, and Di Luca D (2019). KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer’s Disease: Implication for the Role of Herpesvirus Infections. J Alzheimers Dis 67, 1379– 1389. 30689576
  37. Romeo MA, Faggioni A, and Cirone M (2019a). Could autophagy dysregulation link neurotropic viruses to Alzheimer’s disease? Neural Regen Res 14, 1503– 1506. 31089040 PMC6557098
  38. Romeo MA, Masuelli L, Gaeta A, Nazzari C, Granato M, Gilardini Montani MS, Faggioni A, and Cirone M (2019b). Impact of HHV-6A and HHV-6B lytic infection on autophagy and endoplasmic reticulum stress. J Gen Virol 100, 89– 98. 30427305
  39. Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, and Moir RD (2010). The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, e9505. 20209079 PMC2831066
  40. Spitzer P, Condic M, Herrmann M, Oberstein TJ, Scharin-Mehlmann M, Gilbert DF, Friedrich O, Gromer T, Kornhuber J, Lang R, and Maler JM (2016). Amyloidogenic amyloid-beta-peptide variants induce microbial agglutination and exert antimicrobial activity. Sci Rep 6, 32228. 27624303 PMC5021948
  41. Talwar P, Gupta R, Kushwaha S, Agarwal R, Saso L, Kukreti S, and Kukreti R (2019). Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach. Curr Neuropharmacol 17, 352– 365. 29676229 PMC6482477
  42. Virtanen JO, Wohler J, Fenton K, Reich DS, and Jacobson S (2014). Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings. Mult Scler 20, 27– 34. 23722324 PMC5001156
  43. Walker MA, Pedamallu CS, Ojesina AI, Bullman S, Sharpe T, Whelan CW, and Meyerson M (2018). GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts. Bioinformatics 34, 4287– 4289. 29982281 PMC6289130
  44. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, and Selkoe DJ (2002). Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 30, 552– 557. 12196135
  45. Wang M, Beckmann ND, Roussos P, Wang E, Zhou X, Wang Q, Ming C, Neff R, Ma W, Fullard JF, (2018). The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer’s disease. Sci Data 5, 180185. 30204156 PMC6132187
  46. Wipfler P, Dunn N, Beiki O, Trinka E, and Fogdell-Hahn A (2018). The Viral Hypothesis of Mesial Temporal Lobe Epilepsy - Is Human Herpes Virus-6 the Missing Link? A systematic review and meta-analysis. Seizure 54, 33– 40. 29195226
  47. Wozniak MA, Mee AP, and Itzhaki RF (2009). Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J Pathol 217, 131– 138. 18973185
  48. Yao K, Honarmand S, Espinosa A, Akhyani N, Glaser C, and Jacobson S (2009). Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann Neurol 65, 257– 267. 19334059 PMC2666109

Authors
Allnutt, M. A., Johnson, K., Bennett, D. A., Connor, S. M., Troncoso, J. C., Pletnikova, O., Albert, M. S., Resnick, S. M., Scholz, S. W., De Jager, P. L., & Jacobson, S.
Affiliations
  • National Institutes of Health (US)
  • Rush University (US)
  • Columbia University Irving Medical Center (US)
  • Johns Hopkins University (US)
Corresponding author
Jacobson, Steven
Venue
Neuron
Publisher
Elsevier BV
Published
2020-03
Volume
105
Issue
6
Pages
1027-1035.e2
ISSN
0896-6273 (ISSN-L)
OpenAlex
W3001009907
Cited by
119
References
58
Citations by year
2026: 13 · 2025: 7 · 2024: 14 · 2023: 14 · 2022: 26 · 2021: 27 · 2020: 17 · 2019: 1
FWCI
12.63
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Neurological Disorders and Stroke (ZIA-NS003154)
  • Illinois Department of Public Health
  • Icahn School of Medicine at Mount Sinai
  • National Institutes of Health
  • National Institute on Aging (P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152, U01AG61356)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords
human herpesvirus 6, Alzheimer's disease, viral infection, HHV-6A, HHV-6B, Epstein-Barr virus, cytomegalovirus, multi-cohort analysis
MeSH terms
Alzheimer Disease, Brain, Female, Humans, Male, Cohort Studies, Herpesvirus 6, Human, Case-Control Studies, Sequence Analysis, DNA, Sequence Analysis, RNA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review